Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

EMA Recommends Granting a Marketing Authorisation for Aumolertinib

Ogkologos - 8 Ιανουαρίου, 2026

FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer

Ogkologos - 7 Ιανουαρίου, 2026

The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights...

Ogkologos - 22 Δεκεμβρίου, 2025

ESMO Welcomes Launch of Health Package Introducing EU Measures That Can...

Ogkologos - 19 Δεκεμβρίου, 2025

Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer

Ogkologos - 19 Δεκεμβρίου, 2025

Patient Guide in Prostate Cancer Now Available Also in German

Ogkologos - 18 Δεκεμβρίου, 2025

Adding Tafasitamab to Lenalidomide and Rituximab Prolongs PFS in Patients with...

Ogkologos - 18 Δεκεμβρίου, 2025

PFS Non-inferior with Fixed-Duration Treatment with Venetoclax-Obinutuzumab or Venetoclax-Ibrutinib to Continuous...

Ogkologos - 17 Δεκεμβρίου, 2025

Patient Guide on Cancer Pain Management Now Available Also in French

Ogkologos - 16 Δεκεμβρίου, 2025

Patient Guide in Hepatocellular Carcinoma Now Available Also in German

Ogkologos - 16 Δεκεμβρίου, 2025

1...293031...440 Σελίδα 30 από 440

MOST POPULAR

Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years...

25 Αυγούστου, 2026

Daughter Surprises Terminally Ill Mom With Graduation Ceremony In Hospital Room.

16 Μαΐου, 2019

Impressive Responses to PD-1 Blockade in a Large Cohort of Children...

17 Ιανουαρίου, 2022

Cancer in My Community: Bringing Palliative Care to People With Cancer...

21 Φεβρουαρίου, 2023

Φόρτωση περισσοτέρων

EMA Recommends Granting a Marketing Authorisation for Aumolertinib

FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer

The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights...

ESMO Welcomes Launch of Health Package Introducing EU Measures That Can...

Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer

Patient Guide in Prostate Cancer Now Available Also in German

Adding Tafasitamab to Lenalidomide and Rituximab Prolongs PFS in Patients with...

PFS Non-inferior with Fixed-Duration Treatment with Venetoclax-Obinutuzumab or Venetoclax-Ibrutinib to Continuous...

Patient Guide on Cancer Pain Management Now Available Also in French

Patient Guide in Hepatocellular Carcinoma Now Available Also in German

MOST POPULAR

Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years...

Daughter Surprises Terminally Ill Mom With Graduation Ceremony In Hospital Room.

Impressive Responses to PD-1 Blockade in a Large Cohort of Children...

Cancer in My Community: Bringing Palliative Care to People With Cancer...

HOT NEWS

Study Details Long-Term Side Effects of Immune Checkpoint Inhibitors

Quality of Life Is Maintained with First-line Nivolumab Plus Ipilimumab in...

ESMO Congress 2022, 9-13 September

Sister Is There To Comfort Her Little Brother As He Battles...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ